Last reviewed · How we verify
NCT06693232
Mobile Micro-learning on Nurses' Self-confidence, Motivation, and Stress
NA trial testing Mobile micro-learning in Cardiopulmonary Arrest in 100 participants. Completed in 1 January 2026.
1 December 2025
Quick facts
| Lead sponsor | Damanhour University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 November 2024 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 January 2026 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Mobile micro-learning
Conditions studied
- Cardiopulmonary Arrest — all drugs for Cardiopulmonary Arrest →
- Nurse's Role — all drugs for Nurse's Role →
Sponsor
Damanhour University
Who can join
Adults 18 to 60, any sex, with Cardiopulmonary Arrest or Nurse's Role. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Before and after effect of using mobile micro-learning on their self-confidence, motivation, and stress toward cardiopulmonary resuscitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06693232
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiopulmonary Arrest
Currently open trials in the same condition.
- NCT06031623 — REBOA in Nontraumatic OHCA · NA · recruiting
- NCT05784480 — Relevance of Reversible Causes During OHCA (Rebecca Study) · NA · recruiting
- NCT03894059 — An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators · active not recruiting
Other Damanhour University trials
Trials by the same sponsor.
- NCT07307911 — Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy · Phase 2 · completed
- NCT07341893 — Sacubitril-valsartan in Patients With Heart Failure. · NA · recruiting
- NCT07063628 — Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity · completed
- NCT06849388 — Effect of HeartMath Intervention on Stress, Emotional Vitality and Sense of Coherence · NA · recruiting
- NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06693232 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Damanhour University
- Last refreshed: 6 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06693232.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing